Elisa Izquierdo

5PUBLICATIONS
72CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersSolid tumoursGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 24, 2026
Targeted therapies plus radiotherapy for diffuse intrinsic pontine glioma: the randomized phase 2 BIOMEDE trial.

|Oct 20, 2022
Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study.

Olivia Ruhen, Nathalie S M Lak, Janine Stutterheim

|Dec 01, 2021
FGF7-FGFR2 autocrine signaling increases growth and chemoresistance of fusion-positive rhabdomyosarcomas.

Christopher I Milton, Joanna Selfe, Ewa Aladowicz

|Nov 05, 2021
DIPG Harbors Alterations Targetable by MEK Inhibitors, with Acquired Resistance Mechanisms Overcome by Combinatorial Inhibition.

Elisa Izquierdo, Diana M Carvalho, Alan Mackay

|Apr 03, 2020
Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes.

Matthew Clarke, Alan Mackay, Britta Ismer

Pageof 1

Frequent Collaborators

3 joint publications

Michael Hubank

3 joint publications

Darren R Hargrave

2 joint publications

Lynley V Marshall

2 joint publications

Jacques Grill